Module 1: Professional Accountability and Prescribing
Urine drug testing to increase prescription safety
Urine Drug Testing (UDT) is recommended in the Canadian Pain Guidelines for initial assessment and ongoing monitoring of patients compliance when controlled drugs and substances are a part of the management plan. UDT can be conducted as point-of-care testing (POCT) or through a laboratory (or both). Regardless of the approach chosen, providers and patients must have a conversation about the use and purpose for UDT and include it in the treatment agreement. Recommendation R03 outlines the evidence and considerations to keep in mind when using UDTs as part of patient care.